ClinicalTrials.Veeva

Menu

Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton Therapy (MERMOSE)

C

Centre Francois Baclesse

Status

Enrolling

Conditions

Brain Tumor
Proton Therapy
Radiotherapy
Paramedical Consultation

Treatments

Other: Consultation with Manipulator in Medical Radiology and a radiotherapist
Other: Consultation with a radiotherapist

Study type

Interventional

Funder types

Other

Identifiers

NCT05404308
2021-A00499-32

Details and patient eligibility

About

To our knowledge, the investigators have not found any scientific article dealing with cooperation between radiation oncologists and medical radiation technologists in the context of monitoring patients undergoing radiotherapy. Cooperation protocols between health professionals are in progress but concern mainly technical procedures (ultrasound, laserthermal sessions).

This study aims to evaluate whether MERMs, after training by physicians, can monitor clinical signs (for usual well-described toxicities) during treatment via a dedicated consultation.

This approach participates in the development of new professions and cooperation protocols between health professionals. This mission of accompaniment on a dedicated time would make it possible to develop the caring role of the medical electroradiology manipulator.

Enrollment

92 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient > 18 years;
  • Patient with malignant or benign brain or upper aerodigestive tract (ADT) tumor candidate for proton therapy;
  • WHO score < 2
  • Mastery of the French language;
  • Patient affiliated with a social security system;
  • Signature of informed consent prior to any specific procedure related to the study.

Exclusion criteria

  • Patient with another cancer previously treated with radiation therapy;
  • Simultaneous participation in a therapeutic clinical trial;
  • Patient deprived of liberty or under guardianship;
  • Any associated medical or psychological condition that may compromise the patient's ability to participate in the study
  • Patient unable to undergo trial monitoring for geographical, social or psychopathological reasons.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

92 participants in 2 patient groups

Weekly follow-up by a medical radiography technician and weekly follow-up by the radiotherapist
Experimental group
Treatment:
Other: Consultation with Manipulator in Medical Radiology and a radiotherapist
Standard weekly follow-up by the radiotherapist only
Active Comparator group
Treatment:
Other: Consultation with a radiotherapist

Trial contacts and locations

1

Loading...

Central trial contact

Magali MICAUD, Ms

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems